Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Inspire Medical Systems

Biotech & Life Sciences · Golden Valley, United States · Founded 2007 · IPO 2018 Unicorn

Manufacturer of the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea.

Valuation
$1.34B
Market cap · May/2026
Revenue
$912M
Latest reported FY
EBITDA
$213M
Latest reported FY

Investors

7 investors on Inspire Medical Systems's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series B+ 6 investors entered at this stage
Amzak Capital Management
Medtronic
TGap Ventures
OrbiMed
Synergy Life Science Partner
Aperture Venture Partners

Global footprint

Where Inspire Medical Systems has talent and traffic

AI talent share
0.2% of workforce is AI talent
(3 of 1,336 staff)
Core AI10.07%
Other AI20.15%
Non-AI workforce1,33399.78%
Workforce by country
10 countries with
team presence
🇺🇸 United States95.5%
🇩🇪 Germany2.2%
🇫🇷 France0.7%
🇬🇧 United Kingdom0.3%
🇯🇵 Japan0.3%
Top 5 of 10 shown
Web traffic by country
370K monthly visits
across markets
🇺🇸 United States89.2%
🇬🇧 United Kingdom4.3%
🇨🇦 Canada2.1%
🇩🇪 Germany1.4%
🇮🇳 India0.6%
Top 5 markets shown

Patent intelligence

$64M patent portfolio · 81 active families

Estimated portfolio value
$64M
4.8% of market cap · 7.8× smaller than top peer Insulet ($502M)
81 active patent families
Where Inspire Medical Systems innovates Biomedical engineeringPhysical therapyMedical deviceMedical treatmentPhysical medicine and rehabilitation

Where Inspire Medical Systems concentrates vs peers

Each axis is a top-10 topic across Inspire Medical Systems and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Inspire Medical Systems's 3 investments and acquisitions.

Every disclosed deal where Inspire Medical Systems appeared as a backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Inspire Medical Systems's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Inspire Medical Systems deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Inspire Medical Systems's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Inspire Medical Systems

        An AI-synthesized read of the highest-engagement posts about Inspire Medical Systems on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Inspire Medical Systems on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.